NCT00883623
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- University Clinic Heidelberg Heidelberg, Germany
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
NCT00205764
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Wilhelminenspital, 1st Medical Department-center for oncology and hematology Vienna, Austria
Completed
Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
NCT01168804
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Medical University Hospital Graz Graz, Austria
- Hospital Elisabethinen Linz Linz, Austria
- LKH Salzburg, 3rd Med. Dept. Salzburg, Austria
- Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria
NCT00205751
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Wilhelminenspital, 1st Medical Department-center for oncology and hematology Vienna, Austria
NCT00288028
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT00722488
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Winship Cancer Institute Atlanta, Georgia, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01110824
- Conditions
- Acute Myeloid Leukemia, Autologous Hematopoietic Stem Cell Transplantation, Blood Protein Disorders, +25 more
- Locations
-
- Hospital Clinic Barcelona, Catalonia, Spain
- Hospital Clinic Barcelona, Catalonia, Spain
NCT00483262
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
- Washington University in Saint Louis St Louis, Missouri, United States
Completed
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT00317811
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hematology-Oncology Medical Group of Fresno, Incorporated Fresno, California, United States
- Hematology Oncology Medical Group of Orange County, Incorporated Orange, California, United States
- Oncotherapeutics West Hollywood, California, United States
- Florida Cancer Specialists - Bonita Springs Bonita Springs, Florida, United States
NCT00335647
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
- Long Island Jewish Medical Center New Hyde Park, New York, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States